Showing 69,781 - 69,800 results of 103,943 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( e ((nn decrease) OR (point decrease)) ))', query time: 1.18s Refine Results
  1. 69781
  2. 69782
  3. 69783
  4. 69784
  5. 69785
  6. 69786
  7. 69787
  8. 69788
  9. 69789
  10. 69790
  11. 69791
  12. 69792
  13. 69793

    Generation of mu opioid receptor conditional knockout mice. by Raphaël Weibel (458030)

    Published 2013
    “…Genomic DNA was digested using Mfe1 and hybridized to a 3’ external probe, shown in 1A. The expected bands at 8.5 and 15.7 kb were obtained. …”
  14. 69794

    An explanation of the pRF dynamics in terms of feedback signals from extrastriate cortex. by Koen V. Haak (321925)

    Published 2013
    “…Interestingly, this model also predicts that increasing the size of the mask (shifting the fringe to the right) results in a decrease of the pRF expansion. This is indeed what appears to happen when the mask size increases from 5.0° to 7.5° (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0037686#pone-0037686-g004" target="_blank">Figure 4B</a> and corresponding text).…”
  15. 69795

    LRRTM3 Interacts with APP and BACE1 and Has Variants Associating with Late-Onset Alzheimer’s Disease (LOAD) by Sarah Lincoln (160061)

    Published 2013
    “…<i>In-vitro</i> knock-down of <i>LRRTM3</i> was previously shown to decrease secreted Aβ, although the mechanism of this is unclear. …”
  16. 69796

    The expression of genes related to mitochondrial function under the TAC operation. by Junji Okuda (444322)

    Published 2013
    “…Pgam2 overexpression further decreased the expression of some of these genes, such as ERRα, Tfam, MCAD, Cox5a, and Cox7a1 with TAC. …”
  17. 69797

    Supplementary Material for: Tislelizumab vs sorafenib in first-line treatment of unresectable hepatocellular carcinoma: impact on health-related quality of life in RATIONALE-301 st... by Finn R.S. (4148578)

    Published 2024
    “…At cycle 4 and 6, patients in the tislelizumab arm maintained in EQ-5D-5L visual analog scale, whereas scores decreased for the patients in the sorafenib arm. …”
  18. 69798

    Categorising trajectories and individual item changes of the North Star Ambulatory Assessment in patients with Duchenne muscular dystrophy by Francesco Muntoni (228210)

    Published 2019
    “…We utilised latent class trajectory analysis of longitudinal NSAA scores, which produced evidence for at least four clusters of boys sharing similar trajectories versus age in decreasing order of clinical severity: 25% of the boys were in cluster 1 (NSAA falling to ≤ 5 at age ~10y), 35% were in cluster 2 (NSAA ≤ 5 ~12y), 21% in were cluster 3 (NSAA≤ 5 ~14y), and 19% in cluster 4 (NSAA > 5 up to 15y). …”
  19. 69799

    Differentially expressed genes in <i>Tnfr</i>-deficient glomeruli compared to wildtype after TNF stimulation. by Anela Taubitz (433585)

    Published 2013
    “…<b>C:</b> In <i>Tnfr2</i>-deficient glomeruli only 5 genes were differentially expressed, all of them with decreased expression compared to wildtype. …”
  20. 69800

    Glibenclamide alters the subsets of T cells in both spleen and pancreatic-draining lymph nodes. by Smaragda Lamprianou (3599570)

    Published 2016
    “…<p><b>a)</b> After 3 wks of treatment (mice 6 wk of age), FACS analysis showed that the treatment with glibenclamide dose 2 (solid symbols) increased the proportion of the effector subsets of CD44<sup>hi</sup>CD62L<sup>-</sup> T cells, and decreased that of the naïve subset of CD44<sup>lo</sup>CD62L<sup>+</sup> T cells in CD4<sup>+</sup> (top panel) and CD8<sup>+</sup> T cells (bottom panel), as compared to control values (open symbols). …”